Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | JNJ-80948543 |
Trade Name | |
Synonyms | JNJ 80948543|JNJ80948543 |
Drug Descriptions |
JNJ-80948543 is an antibody that targets an undisclosed tumor-associated antigen (TAA) and the T-cell antigen CD3, potentially resulting in activation of cytotoxic T-lymphocytes (CTLs) and tumor cell killing (NCI Drug Dictionary). |
DrugClasses | CD3 Antibody 99 |
CAS Registry Number | NA |
NCIT ID | C188792 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
JNJ-80948543 | JNJ-80948543 | 0 | 1 |
JNJ-80948543 + JNJ-87801493 | JNJ-80948543 JNJ-87801493 | 0 | 1 |